These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
||||||||
(Exact name of registrant as specified in its charter) | ||||||||
|
|
|||||||
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|||||||
|
|
|||||||
|
|
|||||||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | |||||||||
|
par value $0.01 per share
|
|
|
||||||||
|
x | Accelerated filer | o | Non-accelerated filer | o | Smaller reporting company |
|
Emerging growth company |
|
||||||||||||||||||||
TABLE OF CONTENTS | |||||||||||
Page | |||||||||||
March 29, 2024 | September 29, 2023 | ||||||||||
ASSETS | |||||||||||
Current Assets: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Receivables (less allowances: $
|
|
|
|||||||||
Inventories |
|
|
|||||||||
Prepayments and other current assets |
|
|
|||||||||
Current assets of discontinued operations |
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property and Equipment, net |
|
|
|||||||||
Goodwill |
|
|
|||||||||
Other Intangible Assets |
|
|
|||||||||
Operating Lease Right-of-use Assets |
|
|
|||||||||
Other Assets |
|
|
|||||||||
Noncurrent Assets of Discontinued Operations |
|
|
|||||||||
$ |
|
$ |
|
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current Liabilities: | |||||||||||
Current maturities of long-term borrowings | $ |
|
$ |
|
|||||||
Current operating lease liabilities |
|
|
|||||||||
Accounts payable |
|
|
|||||||||
Accrued payroll and related expenses |
|
|
|||||||||
Accrued expenses and other current liabilities |
|
|
|||||||||
Current liabilities of discontinued operations |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Long-Term Borrowings |
|
|
|||||||||
Noncurrent Operating Lease Liabilities |
|
|
|||||||||
Deferred Income Taxes |
|
|
|||||||||
Other Noncurrent Liabilities |
|
|
|||||||||
Noncurrent Liabilities of Discontinued Operations |
|
|
|||||||||
Commitments and Contingencies (see Note 12) |
|
|
|||||||||
Redeemable Noncontrolling Interests |
|
|
|||||||||
Stockholders' Equity: | |||||||||||
Common stock, par value $
|
|
|
|||||||||
Capital surplus |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||
Treasury stock (shares held in treasury:
|
(
|
(
|
|||||||||
Total stockholders' equity |
|
|
|||||||||
$ |
|
$ |
|
Three Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Revenue | $ |
|
$ |
|
|||||||
Costs and Expenses: | |||||||||||
Cost of services provided (exclusive of depreciation and amortization) |
|
|
|||||||||
Depreciation and amortization |
|
|
|||||||||
Selling and general corporate expenses |
|
|
|||||||||
|
|
||||||||||
Operating income |
|
|
|||||||||
Interest Expense, net |
|
|
|||||||||
Income from Continuing Operations Before Income Taxes |
|
|
|||||||||
Provision (Benefit) for Income Taxes from Continuing Operations |
|
(
|
|||||||||
Net income from Continuing Operations |
|
|
|||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
(
|
|||||||||
Net income from Continuing Operations attributable to Aramark stockholders |
|
|
|||||||||
Income from Discontinued Operations, net of tax |
|
|
|||||||||
Net income attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Basic earnings per share attributable to Aramark stockholders: | |||||||||||
Income from Continuing Operations | $ |
|
$ |
|
|||||||
Income from Discontinued Operations |
|
|
|||||||||
Basic earnings per share attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Diluted earnings per share attributable to Aramark stockholders: | |||||||||||
Income from Continuing Operations | $ |
|
$ |
|
|||||||
Income from Discontinued Operations |
|
|
|||||||||
Diluted earnings per share attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Weighted Average Shares Outstanding: | |||||||||||
Basic |
|
|
|||||||||
Diluted |
|
|
|||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements. |
Six Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Revenue | $ |
|
$ |
|
|||||||
Costs and Expenses: | |||||||||||
Cost of services provided (exclusive of depreciation and amortization) |
|
|
|||||||||
Depreciation and amortization |
|
|
|||||||||
Selling and general corporate expenses |
|
|
|||||||||
|
|
||||||||||
Operating income |
|
|
|||||||||
Interest Expense, net |
|
|
|||||||||
Income from Continuing Operations Before Income Taxes |
|
|
|||||||||
Provision for Income Taxes from Continuing Operations |
|
|
|||||||||
Net income from Continuing Operations |
|
|
|||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
(
|
|||||||||
Net income from Continuing Operations attributable to Aramark shareholders |
|
|
|||||||||
Income from Discontinued Operations, net of tax |
|
|
|||||||||
Net income attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Basic earnings per share attributable to Aramark stockholders: | |||||||||||
Income from Continuing Operations | $ |
|
$ |
|
|||||||
Income from Discontinued Operations |
|
|
|||||||||
Basic earnings per share attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Diluted earnings per share attributable to Aramark stockholders: | |||||||||||
Income from Continuing Operations | $ |
|
$ |
|
|||||||
Income from Discontinued Operations |
|
|
|||||||||
Diluted earnings per share attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Weighted Average Shares Outstanding: | |||||||||||
Basic |
|
|
|||||||||
Diluted |
|
|
|||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements. |
Three Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Net income from Continuing Operations | $ |
|
$ |
|
|||||||
Income from Discontinued Operations, net of tax |
|
|
|||||||||
Net income |
|
|
|||||||||
Other comprehensive loss, net of tax | |||||||||||
Foreign currency translation adjustments |
(
|
|
|||||||||
Fair value of cash flow hedges |
|
(
|
|||||||||
Share of equity investee's comprehensive income |
|
|
|||||||||
Other comprehensive loss, net of tax |
(
|
(
|
|||||||||
Comprehensive income |
|
|
|||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
(
|
|||||||||
Comprehensive income attributable to Aramark stockholders | $ |
|
$ |
|
|||||||
Six Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Net income from Continuing Operations | $ |
|
$ |
|
|||||||
Income from Discontinued Operations, net of tax |
|
|
|||||||||
Net income |
|
|
|||||||||
Other comprehensive (loss) income, net of tax | |||||||||||
Foreign currency translation adjustments |
(
|
|
|||||||||
Fair value of cash flow hedges |
(
|
(
|
|||||||||
Share of equity investee's comprehensive loss |
|
(
|
|||||||||
Other comprehensive (loss) income, net of tax |
(
|
|
|||||||||
Comprehensive income |
|
|
|||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
(
|
|||||||||
Comprehensive income attributable to Aramark stockholders | $ |
|
$ |
|
Six Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Cash flows from operating activities of Continuing Operations: | |||||||||||
Net income from Continuing Operations | $ |
|
$ |
|
|||||||
Adjustments to reconcile Net income from Continuing Operations to Net cash used in operating activities of Continuing Operations | |||||||||||
Depreciation and amortization
|
|
|
|||||||||
Asset write-downs |
|
|
|||||||||
Reduction of contingent consideration liability (see Note 14) |
|
(
|
|||||||||
Deferred income taxes |
(
|
|
|||||||||
Share-based compensation expense |
|
|
|||||||||
Changes in operating assets and liabilities: | |||||||||||
Receivables |
(
|
(
|
|||||||||
Inventories
|
|
(
|
|||||||||
Prepayments and Other Current Assets
|
(
|
(
|
|||||||||
Accounts Payable
|
(
|
(
|
|||||||||
Accrued Expenses
|
(
|
(
|
|||||||||
Payments made to clients on contracts
|
(
|
(
|
|||||||||
Other operating activities
|
|
|
|||||||||
Net cash used in operating activities of Continuing Operations |
(
|
(
|
|||||||||
Cash flows from investing activities of Continuing Operations: | |||||||||||
Purchases of property and equipment and other
|
(
|
(
|
|||||||||
Disposals of property and equipment
|
|
|
|||||||||
Purchases of marketable securities |
(
|
(
|
|||||||||
Proceeds from marketable securities |
|
|
|||||||||
Acquisition of certain businesses, net of cash acquired
|
(
|
(
|
|||||||||
Other investing activities
|
(
|
|
|||||||||
Net cash used in investing activities of Continuing Operations |
(
|
(
|
|||||||||
Cash flows from financing activities of Continuing Operations: | |||||||||||
Proceeds from long-term borrowings
|
|
|
|||||||||
Payments of long-term borrowings
|
(
|
(
|
|||||||||
Net change in funding under the Receivables Facility
|
|
|
|||||||||
Payments of dividends
|
(
|
(
|
|||||||||
Proceeds from issuance of common stock
|
|
|
|||||||||
Other financing activities
|
(
|
(
|
|||||||||
Net cash (used in) provided by financing activities of Continuing Operations |
(
|
|
|||||||||
Discontinued Operations: | |||||||||||
Net cash provided by operating activities |
|
|
|||||||||
Net cash used in investing activities |
|
(
|
|||||||||
Net cash used in financing activities |
|
(
|
|||||||||
Net cash provided by Discontinued Operations |
|
|
|||||||||
Effect of foreign exchange rates on cash and cash equivalents and restricted cash |
|
|
|||||||||
Decrease in cash and cash equivalents and restricted cash |
(
|
(
|
|||||||||
Cash and cash equivalents and restricted cash, beginning of period |
|
|
|||||||||
Cash and cash equivalents and restricted cash, end of period | $ |
|
$ |
|
Supplemental disclosure of cash flow information | Six Months Ended | ||||||||||
(in millions) | March 29, 2024 | March 31, 2023 | |||||||||
Interest paid | $ |
|
$ |
|
|||||||
Income taxes paid |
|
|
Balance Sheet classification | |||||||||||
(in thousands) | March 29, 2024 | March 31, 2023 | |||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash in Prepayments and other current assets |
|
|
|||||||||
Cash and cash equivalents in Current assets of discontinued operations |
|
|
|||||||||
Total cash and cash equivalents and restricted cash | $ |
|
$ |
|
Total Stockholders' Equity
|
Common Stock
|
Capital Surplus
|
Retained Earnings
|
Accumulated Other
Comprehensive Loss |
Treasury Stock | ||||||||||||||||||||||||||||||
Balance, September 29, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Net income attributable to Aramark stockholders |
|
|
|||||||||||||||||||||||||||||||||
Other comprehensive loss |
(
|
(
|
|||||||||||||||||||||||||||||||||
Capital contributions from issuance of common stock |
|
|
|
||||||||||||||||||||||||||||||||
Share-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
(
|
|||||||||||||||||||||||||||||||||
Separation of Uniform Segment (see Note 2) |
(
|
(
|
|
||||||||||||||||||||||||||||||||
Payments of dividends ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||
Balance, December 29, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Net income attributable to Aramark stockholders |
|
|
|||||||||||||||||||||||||||||||||
Other comprehensive loss |
(
|
(
|
|||||||||||||||||||||||||||||||||
Capital contributions from issuance of common stock |
|
|
|
||||||||||||||||||||||||||||||||
Share-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
Purchase of noncontrolling
interest |
(
|
(
|
|||||||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
(
|
|||||||||||||||||||||||||||||||||
Separation of Uniform Segment (see Note 2) |
|
|
|||||||||||||||||||||||||||||||||
Payments of dividends ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||
Balance, March 29, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Total Stockholders' Equity
|
Common Stock |
Capital Surplus
|
Retained Earnings
|
Accumulated Other
Comprehensive Loss |
Treasury Stock | ||||||||||||||||||||||||||||||
Balance, September 30, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Net income attributable to Aramark stockholders |
|
|
|||||||||||||||||||||||||||||||||
Other comprehensive income |
|
|
|||||||||||||||||||||||||||||||||
Capital contributions from issuance of common stock |
|
|
|
||||||||||||||||||||||||||||||||
Share-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
Repurchases of common stock |
(
|
(
|
|||||||||||||||||||||||||||||||||
Payments of dividends ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||
Balance, December 30, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Net income attributable to Aramark stockholders |
|
|
|||||||||||||||||||||||||||||||||
Other comprehensive loss |
(
|
(
|
|||||||||||||||||||||||||||||||||
Capital contributions from issuance of common stock |
|
|
|
||||||||||||||||||||||||||||||||
Share-based compensation expense |
|
|
|||||||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
(
|
|||||||||||||||||||||||||||||||||
Payments of dividends ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||
Balance, March 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||||||||||||||
Pre-Tax Amount | Tax Effect | After-Tax Amount | Pre-Tax Amount | Tax Effect | After-Tax Amount | ||||||||||||||||||
Net income | $ |
|
$ |
|
|||||||||||||||||||
Foreign currency translation adjustments |
(
|
|
(
|
|
(
|
|
|||||||||||||||||
Fair value of cash flow hedges |
|
(
|
|
(
|
|
(
|
|||||||||||||||||
Share of equity investee's comprehensive income |
|
|
|
|
|
|
|||||||||||||||||
Other comprehensive loss |
(
|
(
|
(
|
(
|
|
(
|
|||||||||||||||||
Comprehensive income |
|
|
|||||||||||||||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
(
|
|||||||||||||||||||||
Comprehensive income attributable to Aramark stockholders | $ |
|
$ |
|
|||||||||||||||||||
Six Months Ended | |||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||||||||||||||
Pre-Tax Amount | Tax Effect | After-Tax Amount | Pre-Tax Amount | Tax Effect | After-Tax Amount | ||||||||||||||||||
Net income | $ |
|
$ |
|
|||||||||||||||||||
Foreign currency translation adjustments |
(
|
|
(
|
|
(
|
|
|||||||||||||||||
Fair value of cash flow hedges |
(
|
|
(
|
(
|
|
(
|
|||||||||||||||||
Share of equity investee's comprehensive loss |
|
|
|
(
|
|
(
|
|||||||||||||||||
Other comprehensive (loss) income |
(
|
|
(
|
|
|
|
|||||||||||||||||
Comprehensive income |
|
|
|||||||||||||||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
(
|
|||||||||||||||||||||
Comprehensive income attributable to Aramark stockholders | $ |
|
$ |
|
|||||||||||||||||||
March 29, 2024 | September 29, 2023 | ||||||||||
Pension plan adjustments | $ |
(
|
$ |
(
|
|||||||
Foreign currency translation adjustments |
(
|
(
|
|||||||||
Cash flow hedges |
|
|
|||||||||
$ |
(
|
$ |
(
|
Three Months Ended | Six Months Ended | ||||||||||
March 31, 2023 | March 31, 2023 | ||||||||||
Revenue | $ |
|
$ |
|
|||||||
Costs and Expenses: | |||||||||||
Cost of services provided (exclusive of depreciation and amortization) |
|
|
|||||||||
Depreciation and amortization |
|
|
|||||||||
Selling and general corporate expenses |
|
|
|||||||||
|
|
||||||||||
Operating income |
|
|
|||||||||
Interest Expense, net |
|
|
|||||||||
Income from Discontinued Operations Before Income Taxes |
|
|
|||||||||
Provision for Income Taxes from Discontinued Operations |
|
|
|||||||||
Income from Discontinued Operations, net of tax | $ |
|
$ |
|
September 29, 2023 | |||||
ASSETS | |||||
Cash and cash equivalents | $ |
|
|||
Receivables (less allowance: $
|
|
||||
Inventories |
|
||||
Prepayments and other current assets |
|
||||
Current assets of discontinued operations |
|
||||
Property and Equipment, net |
|
||||
Goodwill |
|
||||
Other Intangible Assets |
|
||||
Operating Lease Right-of-use Assets |
|
||||
Other Assets |
|
||||
Noncurrent Assets of Discontinued Operations | $ |
|
|||
LIABILITIES | |||||
Current maturities of long-term borrowings | $ |
|
|||
Current operating lease liabilities |
|
||||
Accounts payable |
|
||||
Accrued payroll and other related expenses |
|
||||
Accrued expenses and other current liabilities |
|
||||
Current liabilities of discontinued operations |
|
||||
Long-Term Borrowings |
|
||||
Noncurrent Operating Lease Liabilities |
|
||||
Deferred Income Taxes |
|
||||
Other Noncurrent Liabilities |
|
||||
Noncurrent Liabilities of Discontinued Operations | $ |
|
FSS United States | $ |
|
|||
FSS International |
|
||||
Corporate |
|
||||
$ |
|
Segment
|
September 29, 2023 | Acquisitions | Translation | March 29, 2024 | |||||||||||||||||||||||||
FSS United States | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
FSS International |
|
|
|
|
|||||||||||||||||||||||||
$ |
|
$ |
|
$ |
|
$ |
|
March 29, 2024 | September 29, 2023 | ||||||||||||||||||||||||||||||||||
Gross Amount | Accumulated Amortization | Net Amount | Gross Amount | Accumulated Amortization | Net Amount | ||||||||||||||||||||||||||||||
Customer relationship assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
Trade names |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
March 29, 2024 | September 29, 2023 | |||||||||||||
Senior secured revolving credit facility, due April 2026 | $ |
|
$ |
|
||||||||||
Senior secured term loan facility, due April 2026 |
|
|
||||||||||||
Senior secured term loan facility, due January 2027 |
|
|
||||||||||||
Senior secured term loan facility, due April 2028 |
|
|
||||||||||||
Senior secured term loan facility, due June 2030 |
|
|
||||||||||||
|
|
|
||||||||||||
|
|
|
||||||||||||
|
|
|
||||||||||||
|
|
|
||||||||||||
Receivables Facility, due July 2026 |
|
|
||||||||||||
Finance leases |
|
|
||||||||||||
Other |
|
|
||||||||||||
|
|
|||||||||||||
Less—current portion |
(
|
(
|
||||||||||||
$ |
|
$ |
|
(1) |
This is a Euro denominated borrowing.
|
Three Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Interest rate swap agreements | $ |
|
$ |
(
|
|||||||
Six Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Interest rate swap agreements | $ |
(
|
$ |
(
|
Balance Sheet Location | March 29, 2024 | September 29, 2023 | ||||||||||||||||||
ASSETS | ||||||||||||||||||||
Interest rate swap agreements | Prepayments and other current assets | $ |
|
$ |
|
|||||||||||||||
Interest rate swap agreements | Other Assets | $ |
|
$ |
|
|||||||||||||||
Three Months Ended | ||||||||||||||||||||
Income Statement Location
|
March 29, 2024 | March 31, 2023 | ||||||||||||||||||
Interest rate swap agreements | Interest Expense, net | $ |
(
|
$ |
(
|
|||||||||||||||
Six Months Ended | ||||||||||||||||||||
Income Statement Location
|
March 29, 2024 | March 31, 2023 | ||||||||||||||||||
Interest rate swap agreements | Interest Expense, net | $ |
(
|
$ |
(
|
|||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | March 29, 2024 | March 31, 2023 | |||||||||||||||||||||||
FSS United States: | ||||||||||||||||||||||||||
Business & Industry | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Education |
|
|
|
|
||||||||||||||||||||||
Healthcare
(1)
|
|
|
|
|
||||||||||||||||||||||
Sports, Leisure & Corrections |
|
|
|
|
||||||||||||||||||||||
Facilities & Other
(1)
|
|
|
|
|
||||||||||||||||||||||
Total FSS United States |
|
|
|
|
||||||||||||||||||||||
FSS International: | ||||||||||||||||||||||||||
Europe |
|
|
|
|
||||||||||||||||||||||
Rest of World |
|
|
|
|
||||||||||||||||||||||
Total FSS International |
|
|
|
|
||||||||||||||||||||||
Total Revenue | $ |
|
$ |
|
$ |
|
$ |
|
(1) |
Beginning in fiscal 2024, management began reporting results for healthcare facility services within "Healthcare", whereas the results were previously reported within "Facilities & Other". As such, the "Healthcare" and "Facilities & Other" results for the three and six months ended March 31, 2023 were recast to reflect this change.
|
March 29, 2024 | September 29, 2023 | |||||||||||||
Deferred income | $ |
|
$ |
|
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | March 29, 2024 | March 31, 2023 | |||||||||||||||||||||||
TBOs | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
TBO-Rs |
|
|
|
|
||||||||||||||||||||||
RSUs |
|
|
|
|
||||||||||||||||||||||
PSUs |
|
|
|
|
||||||||||||||||||||||
Deferred Stock Units |
|
|
|
|
||||||||||||||||||||||
ESPP
(1)
|
|
|
|
|
||||||||||||||||||||||
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Taxes related to share-based compensation | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Cash Received from Option Exercises/ESPP Purchases |
|
|
|
|
||||||||||||||||||||||
Tax Benefit on Share Deliveries |
|
|
|
|
(1) |
The Company suspended its ESPP beginning in the second quarter of fiscal 2023.
|
Shares Granted
(in millions) |
Weighted Average Grant-Date Fair Value
(dollars per share) |
||||||||||
TBOs |
|
$ |
|
||||||||
RSUs |
|
$ |
|
||||||||
PSUs |
|
$ |
|
||||||||
|
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | March 29, 2024 | March 31, 2023 | ||||||||||||||||||||
Earnings: | |||||||||||||||||||||||
Net income from Continuing Operations attributable
to Aramark stockholders
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Income from Discontinued Operations, net of tax |
|
|
|
|
|||||||||||||||||||
Net income attributable to Aramark stockholders | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Shares: | |||||||||||||||||||||||
Basic weighted-average shares outstanding
|
|
|
|
|
|||||||||||||||||||
Effect of dilutive securities |
|
|
|
|
|||||||||||||||||||
Diluted weighted-average shares outstanding
|
|
|
|
|
|||||||||||||||||||
Basic earnings per share attributable to Aramark stockholders: | |||||||||||||||||||||||
Income from Continuing Operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Income from Discontinued Operations |
|
|
|
|
|||||||||||||||||||
Basic earnings per share attributable to Aramark
stockholders
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share attributable to Aramark stockholders: | |||||||||||||||||||||||
Income from Continuing Operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Income from Discontinued Operations |
|
|
|
|
|||||||||||||||||||
Diluted earnings per share attributable to Aramark
stockholders
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | |||||||||||
Revenue | March 29, 2024 | March 31, 2023 | |||||||||
FSS United States | $ |
|
$ |
|
|||||||
FSS International |
|
|
|||||||||
Total Revenue | $ |
|
$ |
|
Three Months Ended | |||||||||||
Operating Income | March 29, 2024 | March 31, 2023 | |||||||||
FSS United States | $ |
|
$ |
|
|||||||
FSS International |
|
|
|||||||||
Total Segment Operating Income |
|
|
|||||||||
Corporate |
(
|
(
|
|||||||||
Total Operating Income | $ |
|
$ |
|
Three Months Ended | |||||||||||
Reconciliation to Income from Continuing Operations Before Income Taxes | March 29, 2024 | March 31, 2023 | |||||||||
Total Operating Income | $ |
|
$ |
|
|||||||
Interest Expense, net |
|
|
|||||||||
Income from Continuing Operations Before Income Taxes | $ |
|
$ |
|
Six Months Ended | |||||||||||
Revenue | March 29, 2024 | March 31, 2023 | |||||||||
FSS United States | $ |
|
$ |
|
|||||||
FSS International |
|
|
|||||||||
Total Revenue | $ |
|
$ |
|
Six Months Ended | |||||||||||
Operating Income | March 29, 2024 | March 31, 2023 | |||||||||
FSS United States | $ |
|
$ |
|
|||||||
FSS International |
|
|
|||||||||
Total Segment Operating Income |
|
|
|||||||||
Corporate |
(
|
(
|
|||||||||
Total Operating Income | $ |
|
$ |
|
Six Months Ended | |||||||||||
Reconciliation to Income from Continuing Operations Before Income Taxes | March 29, 2024 | March 31, 2023 | |||||||||
Total Operating Income | $ |
|
$ |
|
|||||||
Interest Expense, net |
|
|
|||||||||
Income from Continuing Operations Before Income Taxes | $ |
|
$ |
|
Three Months Ended |
Change
|
||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | $ | % | ||||||||||||||||||||
Revenue | $ | 4,199.9 | $ | 3,916.2 | $ | 283.7 | 7.2 | % | |||||||||||||||
Costs and Expenses: | |||||||||||||||||||||||
Cost of services provided (exclusive of depreciation and amortization) | 3,869.2 | 3,621.4 | 247.8 | 6.8 | % | ||||||||||||||||||
Other operating expenses | 171.7 | 169.5 | 2.2 | 1.3 | % | ||||||||||||||||||
4,040.9 | 3,790.9 | 250.0 | 6.6 | % | |||||||||||||||||||
Operating income | 159.0 | 125.3 | 33.7 | 26.9 | % | ||||||||||||||||||
Interest Expense, net | 86.3 | 113.5 | (27.2) | (24.0) | % | ||||||||||||||||||
Income from Continuing Operations Before Income Taxes | 72.7 | 11.8 | 60.9 | *** | |||||||||||||||||||
Provision (Benefit) for Income Taxes from Continuing Operations | 19.7 | (2.3) | 22.0 | *** | |||||||||||||||||||
Net income from Continuing Operations | $ | 53.0 | $ | 14.1 | $ | 38.9 | 275.1 | % | |||||||||||||||
Three Months Ended |
Change
|
|||||||||||||||||||||||||
Revenue by Segment
(1)
|
March 29, 2024 | March 31, 2023 | $ | % | ||||||||||||||||||||||
FSS United States | $ | 3,043.4 | $ | 2,843.2 | $ | 200.2 | 7.0 | % | ||||||||||||||||||
FSS International | 1,156.5 | 1,073.0 | 83.5 | 7.8 | % | |||||||||||||||||||||
$ | 4,199.9 | $ | 3,916.2 | $ | 283.7 | 7.2 | % | |||||||||||||||||||
Three Months Ended | Change | |||||||||||||||||||||||||
Operating Income by Segment | March 29, 2024 | March 31, 2023 | $ | % | ||||||||||||||||||||||
FSS United States | $ | 144.3 | $ | 151.1 | $ | (6.8) | (4.5) | % | ||||||||||||||||||
FSS International | 42.5 | 6.9 | 35.6 | *** | ||||||||||||||||||||||
Corporate | (27.8) | (32.7) | 4.9 | 14.7 | % | |||||||||||||||||||||
$ | 159.0 | $ | 125.3 | $ | 33.7 | 26.9 | % |
Six Months Ended |
Change
|
||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | $ | % | ||||||||||||||||||||
Revenue | $ | 8,607.7 | $ | 7,829.9 | $ | 777.8 | 9.9 | % | |||||||||||||||
Costs and Expenses: | |||||||||||||||||||||||
Cost of services provided (exclusive of depreciation and amortization) | 7,914.3 | 7,213.2 | 701.1 | 9.7 | % | ||||||||||||||||||
Other operating expenses | 367.4 | 339.7 | 27.7 | 8.2 | % | ||||||||||||||||||
8,281.7 | 7,552.9 | 728.8 | 9.6 | % | |||||||||||||||||||
Operating income | 326.0 | 277.0 | 49.0 | 17.7 | % | ||||||||||||||||||
Interest Expense, net | 200.9 | 214.5 | (13.6) | (6.3) | % | ||||||||||||||||||
Income from Continuing Operations Before Income Taxes | 125.1 | 62.5 | 62.6 | 100.2 | % | ||||||||||||||||||
Provision for Income Taxes from Continuing Operations | 43.6 | 10.4 | 33.2 | *** | |||||||||||||||||||
Net income from Continuing Operations | $ | 81.5 | $ | 52.1 | $ | 29.4 | 56.5 | % | |||||||||||||||
Six Months Ended |
Change
|
|||||||||||||||||||||||||
Revenue by Segment
(1)
|
March 29, 2024 | March 31, 2023 | $ | % | ||||||||||||||||||||||
FSS United States | $ | 6,256.2 | $ | 5,764.2 | $ | 492.0 | 8.5 | % | ||||||||||||||||||
FSS International | 2,351.5 | 2,065.7 | 285.8 | 13.8 | % | |||||||||||||||||||||
$ | 8,607.7 | $ | 7,829.9 | $ | 777.8 | 9.9 | % | |||||||||||||||||||
Six Months Ended | Change | |||||||||||||||||||||||||
Operating Income by Segment | March 29, 2024 | March 31, 2023 | $ | % | ||||||||||||||||||||||
FSS United States | $ | 319.1 | $ | 309.7 | $ | 9.4 | 3.0 | % | ||||||||||||||||||
FSS International | 88.8 | 33.7 | 55.1 | 164.0 | % | |||||||||||||||||||||
Corporate | (81.9) | (66.4) | (15.5) | (23.5) | % | |||||||||||||||||||||
$ | 326.0 | $ | 277.0 | $ | 49.0 | 17.7 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | March 29, 2024 | March 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cost of services provided (exclusive of depreciation and amortization) | $ | % of Revenue | $ | % of Revenue | $ | % of Revenue | $ | % of Revenue | |||||||||||||||||||||||||||||||||||||||||||||
FSS United States | $ | 2,778.5 | 91.3 | % | $ | 2,576.7 | 90.6 | % |
(1)
|
$ | 5,697.8 | 91.1 | % | $ | 5,223.1 | 90.6 | % |
(1)
|
|||||||||||||||||||||||||||||||||||
FSS International | 1,090.7 | 94.3 | % | 1,044.7 | 97.4 | % |
(2)
|
2,216.5 | 94.3 | % | 1,990.1 | 96.3 | % |
(2)
|
|||||||||||||||||||||||||||||||||||||||
$ | 3,869.2 | 92.1 | % | $ | 3,621.4 | 92.5 | % | $ | 7,914.3 | 91.9 | % | $ | 7,213.2 | 92.1 | % |
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
Cost of services provided (exclusive of depreciation and amortization) components | March 29, 2024 | March 31, 2023 | March 29, 2024 | March 31, 2023 | ||||||||||||||||||||||
Food and support service costs
(1)
|
29.8 | % | 30.3 | % | 30.2 | % | 30.5 | % | ||||||||||||||||||
Personnel costs
(2)
|
45.4 | % | 46.6 | % | 44.6 | % | 45.8 | % | ||||||||||||||||||
Other direct costs
(3)
|
24.8 | % | 23.1 | % | 25.2 | % | 23.7 | % | ||||||||||||||||||
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % |
Three Months Ended | Change | Six Months Ended | Change | ||||||||||||||||||||||||||||||||
March 29, 2024 | March 31, 2023 | % | March 29, 2024 | March 31, 2023 | % | ||||||||||||||||||||||||||||||
Business & Industry | $ | 396.7 | $ | 343.2 | 15.6 | % | $ | 779.8 | $ | 674.7 | 15.6 | % | |||||||||||||||||||||||
Education | 1,039.5 | 983.7 | 5.7 | % | 2,151.8 | 1,987.3 | 8.3 | % | |||||||||||||||||||||||||||
Healthcare
(1)
|
405.5 | 422.4 | (4.0) | % | 804.6 | 834.8 | (3.6) | % | |||||||||||||||||||||||||||
Sports, Leisure & Corrections | 763.6 | 676.0 | 13.0 | % | 1,667.2 | 1,460.6 | 14.1 | % | |||||||||||||||||||||||||||
Facilities & Other
(1)
|
438.1 | 417.9 | 4.8 | % | 852.8 | 806.8 | 5.7 | % | |||||||||||||||||||||||||||
$ | 3,043.4 | $ | 2,843.2 | 7.0 | % | $ | 6,256.2 | $ | 5,764.2 | 8.5 | % |
(1) |
Beginning in fiscal 2024, management began reporting results for healthcare facility services within "Healthcare", whereas the results were previously reported within "Facilities & Other". As such, the "Healthcare" and "Facilities & Other" three and six months ended March 31, 2023 results were recast to reflect this change.
|
Six Months Ended | |||||||||||
March 29, 2024 | March 31, 2023 | ||||||||||
Net cash used in operating activities of Continuing Operations | $ | (435.8) | $ | (362.4) | |||||||
Net cash used in investing activities of Continuing Operations | (289.8) | (204.2) | |||||||||
Net cash (used in) provided by financing activities of Continuing Operations | (833.0) | 486.1 |
Twelve Months Ended | |||||
(in millions)
|
March 29, 2024 | ||||
Net income Attributable to ASI stockholders | $ | 625.9 | |||
Less: Income from Discontinued Operations, net of tax | (149.0) | ||||
Net income from Continuing Operations Attributable to ASI stockholders | $ | 476.9 | |||
Interest expense, net | 423.9 | ||||
Provision for Income Taxes | 149.6 | ||||
Depreciation and Amortization | 418.7 | ||||
Share-based compensation expense
(1)
|
66.7 | ||||
Unusual or non-recurring gains
(2)
|
(373.7) | ||||
Pro forma EBITDA for certain transactions
(3)
|
5.8 | ||||
Other
(4)
|
117.0 | ||||
Covenant Adjusted EBITDA
|
$ | 1,284.9 |
Covenant
Requirement |
Actual
Ratio |
||||||||||
Consolidated Secured Debt Ratio
(1)
|
≤ 5.125x | 2.75x | |||||||||
Interest Coverage Ratio (Fixed Charge Coverage Ratio)
(2)
|
≥ 2.000x | 3.62x |
Aramark | ||||||||||||||||||||
By: | /s/ CHRISTOPHER T. SCHILLING | |||||||||||||||||||
Name: | Christopher T. Schilling | |||||||||||||||||||
Title: |
Senior Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer and Authorized Signatory) |
Exhibit No. |
Description
|
|||||||
The following financial information from Aramark's Quarterly Report on Form 10-Q for the period ended
March
29, 202
4
formatted in inline XBRL: (i) Condensed Consolidated Balance Sheets as of
March
29, 202
4
and September 29, 2023; (ii) Condensed Consolidated Statements of Income for the three
and six
months ended
March
29, 202
4
and
March 31
, 202
3
; (iii) Condensed Consolidated Statements of Comprehensive Income for the three
and six
months ended
March
29, 202
4
and
March 31
, 202
3
; (iv) Condensed Consolidated Statements of Cash Flows for the
six
months ended
March
29, 20
24
and
March 31
, 202
3
; (v) Condensed Consolidated Statements of Stockholders' Equity for the three
and six
months ended
March
29, 202
4
and
March 31
, 202
3
; and (vi) Notes to condensed consolidated financial statements.
|
||||||||
104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q; included in Exhibit 101 Inline XBRL document set. |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Virgil L. Winland retired from his position as Senior Vice President of Manufacturing at the Company in 2021 after 50 years of service. Mr. Winland was employed at Lennox Industries when the Company acquired its cylinders business in 1971. After various roles with the legacy pressure cylinders division, he became Vice President of Manufacturing in 1985 and Group Vice President of Worthington Cylinders in 1995. Two years later, Mr. Winland became Group President of Worthington Cylinders. Mr. Winland was named Senior Vice President of Manufacturing for the Company in 2001, where he was responsible for coordinating best practices throughout all business units, drove cost reduction efforts and worked to assess, develop and monitor manufacturing plants across the Company. Mr. Winland’s knowledge and depth of experience in manufacturing, leading strategic initiatives, managing and developing human capital, and the Company’s history and Philosophy make him well qualified to serve on the Board. | |||
Paul G. Heller was appointed as a director of the Company in December 2023. He retired in March 2024 as senior Executive Vice President and Chief Technology and Operations Officer at Huntington Bancshares Incorporated where he led the bank’s information technology, payments, cyber security, digital, corporate operations and customer contact center initiatives. Prior to joining Huntington in 2012, Mr. Heller was the managing director for the corporate internet group at JP Morgan Chase. Mr. Heller is an active member of the Central Ohio community, serving as a member of the Board of Trustees for the Center of Science and Industry (COSI), an Endowment Board member at Saint Charles Preparatory School and member of the board of directors of The Ohio State University’s CampusParc. Mr. Heller earned a Bachelor of Science in Finance from Miami University and a Master of Business Administration from The Ohio State University Fisher School of Business. Mr. Heller's knowledge and depth of experience in technology, strategic matters, financial analysis and risk management make him well qualified to serve on the Board. | |||
Ozey K. Horton, Jr. has served continuously as a director of the Company since 2011 and is a member of the Compensation Committee and the Nominating and Governance Committee. He is an independent advisor and serves as Director Emeritus of McKinsey & Company, a management consulting firm, from which he retired in February 2011. Prior to that time, Mr. Horton served as a Director of McKinsey & Company from 1981 through February 2011. Prior to his service with McKinsey & Company, Mr. Horton had early career experiences in manufacturing, corporate development and project engineering. Mr. Horton has served as a director of Louisiana-Pacific Corporation, a global leader in engineered wood products, since September 2016 where he serves as a member of its Finance & Audit Committee and its Nominating and Corporate Governance Committee. In 2018, he became a director of ArborGen Holdings Limited, a producer of genetic tree seedling products. Mr. Horton serves on the Dabbagh Group Holding Co. Ltd. Advisory Board. He also serves as a member of the MUSC Hollings Cancer Center Advisory Board, and the Liberty Fellows Senior Advisor Group. He formerly served as a member of the Metso Corporation Board and The Board of Visitors of the Pratt School of Engineering/Duke University. Mr. Horton has extensive experience working in Europe, South America, India and Asia. Mr. Horton has a Bachelor of Science in Engineering in civil and environmental engineering from Duke University and a Master of Business Administration from the Harvard Business School. Over the years, Mr. Horton led numerous corporate growth, strategic, mergers and acquisitions, and performance improvement initiatives at global clients across a range of industries — especially in the basic industrials space (such as metals and mining; pulp, paper and packaging; chemicals; and energy). He has also led several practices within McKinsey & Company: as founder of the global pulp, paper, and packaging practice; co-leader of the global basic materials practice; and leader of the global operations practice within the energy and materials sector. Mr. Horton’s wide-ranging experience working with manufacturing and other companies, both domestically and globally, provides unique expertise to the Board, and all of the attributes described above make him well suited to serve on the Board. | |||
Michael J. Endres has served continuously as a director of the Company since 1999 and is a member of the Executive Committee and the Compensation Committee. Mr. Endres serves as Senior Advisor to Stonehenge Partners, Inc., a private equity investment firm he co-founded in August 1999. His duties include, among other things, providing advice related to specific company financial characteristics, balance sheet and income statement analysis, as well as industry growth rates and trends, and managing the acquisition and disposition of the firm’s investments. Mr. Endres served as a director of Huntington Bancshares Incorporated from April 2003 to April 2018. Mr. Endres served as a director of W.W. Williams Company, a diversified aftermarket parts and service provider to the commercial vehicle and equipment markets, from October 2011 to 2016, and formally served as a director of TRI-W Group (successor to W.W. Williams Company). He has been a director and Chairman of Conterra AG, a real estate finance company, since 2014; and Calibre Group LLC, an industrial-focused private equity firm, since 2015. Mr. Endres served as a director of Tim Hortons Inc. from 2006 until December 2014 (when it was acquired by Restaurant Brands International), where he was Chair of its Audit Committee and a member of its Executive Committee. Mr. Endres received a Bachelor of Science from Miami University. Mr. Endres has a depth of experience in equity investing, business development, strategic initiatives and acquisitions, financial analysis, leadership and management, and is a director of various companies. | |||
Mark C. Davis has served continuously as a director of the Company since 2011 and is a member of the Audit Committee. Mr. Davis is a private investor and the CEO of Lank Acquisition Corp., which invests in minority and majority positions in public and private companies. Prior to forming Lank Acquisition Corp. in 2007, Mr. Davis spent 20 years in a variety of senior investment banking positions. From 1996 to 2003, Mr. Davis was a senior executive at JPMorgan Chase where he began as Head of the Merger and Acquisition Group. He became Head of General Industry Investment Banking in 2000 and was also Co-Head of Investment Banking Coverage which comprised all of JPMorgan Chase’s corporate clients, and was named Vice Chairman of Investment Banking in 2002. Mr. Davis holds a Master of Business Administration from the Tuck School of Business and a Bachelor of Arts from Dartmouth College. Mr. Davis’ financial knowledge and depth of experience in equity investing, strategic matters, acquisitions, financial analysis and investment banking make him well qualified to continue to serve on the Board, and qualify him as an “audit committee financial expert”, as defined by SEC Rules. | |||
Kerrii B. Anderson has served continuously as a director of the Company since September 2010 and is a member of the Audit Committee and the Compensation Committee. Ms. Anderson has been a private investor and board advisor since September 2008. Prior to that time, she served as CEO and President of Wendy’s International, Inc. (now known as The Wendy’s Company), a restaurant operating and franchising company, from November 2006 until September 2008 when that company merged with a subsidiary of Triarc Companies, Inc. to form Wendy’s/Arby’s Group, Inc. She served as a director of Wendy’s International, Inc. from 2001 until September 2008, and as Wendy’s Interim CEO and President from April to November 2006 and as its Executive Vice President and CFO from 2000 to April 2006. Previously, Ms. Anderson served as Senior Vice President and CFO of M/I Schottenstein Homes, Inc. (now known as M/I Homes, Inc.), a builder of single-family homes, from 1987 to 2000. Ms. Anderson has served as a member of the board of directors of Labcorp Holdings, Inc. since May 2006, where she is member of its Audit Committee and a member of its Nominating and Board Governance Committee. She joined the board of directors of Abercrombie & Fitch Co. in February 2018 and is the Chair of its Audit and Finance Committee and serves on the Nominating and Governance Committee. She also joined the board of directors of The Sherwin-Williams Company in April 2019 and has chaired its Compensation and Management Development Committee since April 2021, where she is Chair of the Compensation and Management Development Committee and a member of the Nominating and Corporate Governance Committee. Previously, she served as a member of the board of directors of Chiquita Brands International, Inc. from 2009 to January 2015, including service as Chairwoman of the Board from October 2012 to January 2015, as Chair of its Nominating and Governance Committee and as a member of its Audit Committee until January 2015 when Chiquita was acquired by Cavendish Global Limited and became a private company; and as a member of the board of directors of P. F. Chang’s China Bistro, Inc. from 2009 until July 2012 when P.F. Chang’s was acquired by Wok Acquisition Corp. Ms. Anderson chairs the Finance Committee of The Columbus Foundation and is a member of the OhioHealth Corporation Executive Compensation Committee. She is a Certified Public Accountant and qualifies as an “audit committee financial expert”, as defined by SEC Rules, given her experience as a CEO and CFO of other large, publicly traded companies. Ms. Anderson received a B.A. from Elon University and a Master of Business Administration from the Duke University Fuqua School of Business. Ms. Anderson’s extensive corporate governance experience through her service on other public company boards, her extensive experience in accounting and financial reporting and analysis, strong record of leadership in operations and strategy, and prior experience as a CEO of a public company and CFO of several public companies, in addition to other public company board service, make Ms. Anderson a valuable asset to the Board and its various committees, and well qualified to serve on the Board. Ms. Anderson also received the NACD CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University. | |||
John H. McConnell II was appointed as a director of the Company in January 2023 and is a member of the Executive Committee. Mr. McConnell has served as the Chairman of the Board of JMAC, Inc., a private investment company, since September 2023. Mr. McConnell was Vice President, Global Business Development, of the Company's former Sustainable Energy Solutions business from June 2021 until December 2023. He also previously served as Business Director of the Company's North American High Pressure Vessels business from November 2019 to June 2021 and Product Manager of the Company's Life Support Technology products from June 2014 to November 2019. Mr. McConnell also held various roles with the Company from 2000 to 2012, and with the Columbus Blue Jackets, a National Hockey League team, from 2012 to 2014. Mr. McConnell holds a Bachelor of Arts in Strategic Communications and a Master of Business Administration from The Ohio State University. Mr. McConnell serves on the boards of the National Veterans Memorial and Museum, the Columbus Zoo and Aquarium and the Cohesion Foundation. Mr. McConnell's long association with the Company, the governance skills he has developed serving on various other boards, and the variety of roles in which he has served the Company and other organizations make him well qualified to continue to serve on the Board. In addition, as the Company’s largest shareholder, the McConnell family members have a strong interest in the continuing success of the Company and have always played an important role in the business. Mr. McConnell's participation on the Board ensures that commitment to successful stewardship continues. | |||
John B. Blystone has served as the Chairman of the Board of the Company since December 2023, the Chair of our Executive Committee since September 2023 and a director of the Company since 1997. He served as our Executive Chairman from September 2023 through November 2023 and as our Lead Independent Director from January 2007 until September 2023. Mr. Blystone has served as the Executive Chairman of the Board of Worthington Steel, Inc. since the Separation in December 2023. Mr. Blystone served as Chairman of the Board, President and CEO of SPX Corporation, a global provider of technical products and systems, industrial products and services, flow technology, cooling technologies and services and service solutions, from December 1995 to December 2004, when he retired. From 1991 to 1995, Mr. Blystone served in various managerial and operating roles with General Electric Company. Mr. Blystone served as Chairman of the Board of Freedom Group, Inc., which manufactures and markets firearms, ammunition and related products, from August 2010 to March 2012. Mr. Blystone serves as a director for Blystone Consulting, LLC and as General Partner of Blystone Capital Partners. Mr. Blystone graduated from the University of Pittsburgh with a Bachelor of Arts in Mathematics and Economics. Mr. Blystone has extensive business experience in managing and operating both domestic and international operations, including as a chief executive officer of a large public company. He has expertise in acquisitions, financial and business analysis, and in generally managing issues that face a large public company. In addition to the experiences and skills previously noted, Mr. Blystone’s business acumen, his long service on the Board, and his collegial style and leadership resulted in his election as the Chairman of the Board and make him well qualified to continue to serve as a director. | |||
David P. Blom has served continuously as a director of the Company since June 2019 and is a member of the Nominating and Governance Committee. Mr. Blom served as President and CEO of OhioHealth Corporation, a not-for-profit, healthcare system in central Ohio, from March 2002 until his retirement in June 2019. Mr. Blom previously served as President of OhioHealth’s central Ohio hospitals – Grant Medical Center, Riverside Methodist Hospital and Doctors Hospital – while also serving as Executive Vice President and Chief Operating Officer of OhioHealth. Mr. Blom currently serves as a member of the board of directors for several organizations, including Healthy Roster since 2017, Vizient Inc. since 2011, Methode Electronics since 2019 and Kimball Midwest Advisory Council since 2015. Mr. Blom previously served on the board of directors of The Columbus Foundation from 2011 to 2017 and the board of directors of Dominion Homes, Inc. from 2006 to 2009. Mr. Blom holds a Master of Health Services Administration in Healthcare Administration from George Washington University, and a Bachelor of Arts in Business Administration from The Ohio State University. Mr. Blom has a track record of achievement and a solid understanding of complex issues, particularly those facing healthcare delivery. He has expertise in leading strategic initiatives, managing and developing human capital, improving profitability, and improving quality of care and customer experience, which enables him to bring a unique and valuable perspective to the Board, and makes him well qualified to serve on the Board. | |||
Billy R. Vickers was appointed as a director of the Company in December 2023. He is President and CEO Modular Assembly Innovations, LLC (“MAI”). One of the largest minority-owned businesses in the country, MAI is the parent company of Great Lakes Assemblies, Gulf Shore Assemblies, Indiana Assemblies and North American Assemblies. These locations span four states, employ approximately 400 associates and generate more than $1.2 billion in revenue. Mr. Vickers holds a Bachelor of Science in Animal Science from North Carolina State University and has completed the Kellogg Advance Management Education Program at Northwestern University. Mr. Vickers began his manufacturing career at Ironton Castings in Ironton, Ohio and went on to earn various leadership roles and achieve successful entrepreneurial pursuits throughout his more than 35-year career. Mr. Vickers also serves on the Boards of Directors for the Nationwide Children's Hospital Foundation, Fifth Third Bank Advisory Board and A Kid Again National Office and is a member of the Columbus Partnership, the Ohio Manufacturers’ Association and the Federal Reserve Bank of Cleveland, Columbus Advisory Council. Mr. Vickers' knowledge and depth of experience in manufacturing, leading strategic initiatives, managing and developing human capital, and improving performance and profitability make him well qualified to serve on the Board. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Plan
|
|
|
|
|
|
|
||||||||
Name and Principal Position During Fiscal 2024 |
|
Fiscal Year |
|
Salary
|
|
Discretionary
|
|
|
|
Stock
|
|
|
Option
|
Annual
|
|
3-year Cash
|
|
All Other
|
|
Total ($) |
||||||||||||||
B. Andrew Rose |
|
2024 |
|
|
|
814,904 |
|
|
|
0 |
|
|
|
3,961,405 |
|
|
|
430,770 |
|
|
1,626,240 |
|
|
|
3,146,666 |
|
|
|
130,983 |
|
|
|
10,110,968 |
|
President & Chief Execuive Officer |
|
2023 |
|
|
|
735,038 |
|
|
|
0 |
|
|
|
2,246,806 |
|
|
|
415,798 |
|
|
1,047,900 |
|
|
|
2,666,666 |
|
|
|
167,578 |
|
|
|
7,279,786 |
|
|
|
2022 |
|
|
|
668,038 |
|
|
|
0 |
|
|
|
2,533,999 |
|
|
|
333,944 |
|
|
1,860,000 |
|
|
|
2,000,000 |
|
|
|
141,943 |
|
|
|
7,537,924 |
|
Joseph B. Hayek |
|
2024 |
|
|
|
529,471 |
|
|
|
250,000 |
|
|
|
2,708,391 |
|
|
|
150,510 |
|
|
937,200 |
|
|
|
1,000,000 |
|
|
|
90,155 |
|
|
|
5,665,727 |
|
Executive Vice President & |
|
2023 |
|
|
|
490,769 |
|
|
|
0 |
|
|
|
691,211 |
|
|
|
126,049 |
|
|
613,770 |
|
|
|
840,000 |
|
|
|
103,769 |
|
|
|
2,865,568 |
|
Chief Financial & Operations Officer |
|
2022 |
|
|
|
441,519 |
|
|
|
0 |
|
|
|
517,634 |
|
|
|
104,728 |
|
|
1,100,000 |
|
|
|
706,666 |
|
|
|
105,014 |
|
|
|
2,975,561 |
|
Patrick J. Kennedy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vice President, General Counsel |
|
2024 |
|
|
|
420,592 |
|
|
|
250,000 |
|
|
|
1,219,820 |
|
|
|
51,900 |
|
|
454,080 |
|
|
|
283,334 |
|
|
|
53,368 |
|
|
|
2,733,094 |
|
& Secretary |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sonya L. Higginbotham |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior Vice President & Chief of Corporate Affairs, |
|
2024 |
|
|
|
246,608 |
|
|
|
150,000 |
|
|
|
1,098,492 |
|
|
|
30,735 |
|
|
246,381 |
|
|
|
150,000 |
|
|
|
98,015 |
|
|
|
2,020,231 |
|
Communications & Sustainability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steven M. Caravati |
|
2024 |
|
|
|
358,503 |
|
|
|
0 |
|
|
|
929,420 |
|
|
|
51,900 |
|
|
360,720 |
|
|
|
150,000 |
|
|
|
48,838 |
|
|
|
1,899,381 |
|
President, Consumer Products |
|
2023 |
|
|
|
334,815 |
|
|
|
0 |
|
|
|
1,298,194 |
|
|
|
39,288 |
|
|
243,146 |
|
|
|
155,900 |
|
|
|
37,596 |
|
|
|
2,108,939 |
|
Geoffrey G. Gilmore |
|
2024 |
|
|
|
338,946 |
|
|
|
0 |
|
|
|
729,435 |
|
|
|
142,725 |
|
|
588,652 |
|
|
|
1,073,332 |
|
|
|
14,460 |
|
|
|
2,887,551 |
|
Former Executive Vice President |
|
2023 |
|
|
|
656,515 |
|
|
|
0 |
|
|
|
774,713 |
|
|
|
145,693 |
|
|
810,176 |
|
|
|
1,026,668 |
|
|
|
99,462 |
|
|
|
3,513,227 |
|
& Chief Operations Officer |
|
2022 |
|
|
|
630,669 |
|
|
|
0 |
|
|
|
601,900 |
|
|
|
122,512 |
|
|
1,550,001 |
|
|
|
946,668 |
|
|
|
109,721 |
|
|
|
3,961,471 |
|
John P. McConnell |
|
2024 |
|
|
|
144,859 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
207,133 |
|
|
|
2,000,000 |
|
|
|
12,062 |
|
|
|
2,364,054 |
|
Former Executive Chairman |
|
2023 |
|
|
|
426,452 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
427,623 |
|
|
|
1,676,456 |
|
|
|
48,902 |
|
|
|
2,579,433 |
|
|
|
2022 |
|
|
|
410,861 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
824,000 |
|
|
|
3,320,600 |
|
|
|
48,383 |
|
|
|
4,603,844 |
|
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
MCCONNELL JOHN P/OH | - | 1,338,630 | 44,250 |
ROSE B ANDREW | - | 437,698 | 10,665 |
ROSE B ANDREW | - | 425,195 | 10,665 |
HAYEK JOSEPH B | - | 195,383 | 1,617 |
HAYEK JOSEPH B | - | 186,990 | 1,656 |
GILMORE GEOFFREY G | - | 174,471 | 0 |
HAYEK JOSEPH B | - | 141,880 | 1,617 |
SMOLENSKI ERIC M | - | 85,857 | 7,576 |
SCHIAVO MARY FACKLER | - | 80,574 | 0 |
ENDRES MICHAEL J | - | 76,689 | 66,000 |
ANDERSON KERRII B | - | 71,334 | 436 |
HORTON OZEY K JR | - | 41,688 | 0 |
McConnell John H II | - | 30,950 | 245 |
Kennedy Patrick J. | - | 18,998 | 0 |
Kennedy Patrick J. | - | 18,355 | 0 |
HIGGINBOTHAM SONYA L | - | 17,413 | 434 |
SOUZA COLIN J | - | 15,752 | 1 |
BOWES JAMES R | - | 13,894 | 0 |
Witt Steven R | - | 6,930 | 0 |
CHAN KEVIN J | - | 5,589 | 2,783 |
Standridge Brantley J | - | 1,650 | 0 |
LYTTLE CATHERINE M | - | 142 | 0 |